Evolution of hepatitis C virus quasispecies in children with chronic hepatitis C

Infection

Volumn 34, Issue 2, 2006, Pages 62-65

  Gerotto, M ^a   Resti, M ^b   Dal Pero, F ^a   Migliorato, I ^d   Alberti, A ^a   Bortolotti, F ^c  

^a VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Clinica Medica 3   (Italy)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HETERODUPLEX; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; ENVIRONMENTAL FACTOR; EVOLUTION; FEMALE; FOLLOW UP; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; HOST RESISTANCE; HUMAN; MALE; PERSISTENT VIRUS INFECTION; PRESCHOOL CHILD; SCHOOL CHILD; VIRUS GENOME;

CHILD; CHILD, PRESCHOOL; EVOLUTION, MOLECULAR; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HETERODUPLEX ANALYSIS; HUMANS; INFANT; MALE; POLYMERASE CHAIN REACTION; RNA, VIRAL; VARIATION (GENETICS); VIRAL PROTEINS;

EID: 33646731379     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-006-5037-4     Document Type: Article

References (22)

1. Farci P, Purcell RH: Clinical significance of hepatitis C virus genotypes and quasispecies. Semin Liver Dis 2000; 20:103-126.
2. Weiner AJ, Brauer MJ, Rosenblatt J, Richman KH, Tung J, Crawford K, Bonino F, Saracco G, Choo QL, Houghton M: Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991; 180: 842-848.
3. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K: Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 1991; 175: 220-228.
4. Kumar U, Monjardino J, Thomas HC: Hypervariable region of hepatitis C envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology 1994; 106: 1072-1075.
5. Lawal Z, Petrik J, Wong VS, Alexander GJ, Allain JP: Hepatitis C virus genomic variability in untreated and immunosuppressed patients. Virology 1997; 28: 107-111.
6. Booth JC, Kumar U, Webster D, Monjardino J, Thomas HC: Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Hepatology 1998; 27: 223-227.
7. Kudo T, Yanase Y, Ohshiro M, Yamamoto M, Morita M, Shibata M, Morishima T: Analysis of mother-to-infant transmission of hepatitis C virus: quasispecies nature and buoyant densities of maternal viral populations. J Med Virol 1997; 51: 225-230.
8. Ni YH, Chang MH, Chen PJ, Lin HH, Hsu HY: Evolution of hepatitis C virus quasispecies in mothers and infants infected through mother-to-infant transmission. J Hepatol 1997; 26: 967-974.
9. Murakami J, Okamoto M, Miyata H, Nagata I, Shiraki K, Hino S: Evolution in the hypervariable region of hepatitis C virus in infants after vertical transmission. Pediatr Res 2000; 48: 450-456.
10. Manzin A, Solforosi L, Debiaggi M, Zara F, Tanzi E, Romano L, Zanetti AR, Clementi M: Dominant role of host selective pressure in driving hepatitis C virus evolution in perinatal infection. J Virol 2000; 74: 4327-4334.
11. Honda M, Kaneko S, Sakai A, Masashi U, Murakami S, Kobayashi K: Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology 1994; 20: 1144-1151.
12. Yuki N, Hayashi N, Moribe T, Matsushita Y, Tabata T, Inoue T, Kanazawa Y, Ohkawa K, Kasahara A, Fusamoto H, Kamada T: Relation of disease activity during chronic hepatitis C infection to complexity of hypervariable region 1 quasispecies. Hepatology 1997; 25: 439-444.
13. Naito M, Hayashi N, Moribe T, Hagiwara H, Mita E, Kanazawa Y, Kasahara A, Fusamoto H, Kamada T: Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease. Hepatology 1995; 22: 407-412.
14. Le Guen B, Squadrito G, Nalpas B, Berthelot P, Pol S, Brechot C: Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C. Hepatology 1997; 25: 1250-1254.
15. Pawlotsky JM, Pellerin M, Bouvier M, Roudot-Thoraval F, Germanidis G, Bastie A, Darthuy F, Remire J, Soussy CJ, Dhumeaux D: Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C. J Med Virol 1998; 54: 256-264.
16. Gerotto M, Sullivan DG, Polyak SJ, Chemello L, Cavalletto L, Pontisso P, Alberti A, Gretch DR: Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in non-responder patients with chronic hepatitis C. J Virol 1999; 73: 7241-7247.
17. Polyak S, Faulkner G, Carithers R, Corey L, Gretch D: Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis. Correlation with response to interferon therapy. J Infect Dis 1997; 175: 1101-1117.
18. Gonzalez-Peralta RP, Qian K, She JY, Davis GL, Ohno T, Mizokami M, Lau JY: Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C. J Med Virol 1996; 49: 242-247.
19. Canobio S, Guilbert CM, Troesch M, Samson J, Lemay M, Pelletier VA, Bonnin Bernard AC, Kozielski R, Lapointe N, Martin SR, Soudeyns A: Differing patterns of liver disease progression and hepatitis C virus (HCV) quasispecies evolution in children vertically coinfected with HCV and human immunodeficiency virus type 1. J Clin Microbiol 2004; 42: 4365-4369.
20. Pollack H, Hou Z, Hughes AL, Borkowsky W: Perinatal transmission and viral evolution of hepatitis C virus quasispecies in infants coinfected with HIV. J Acquir Immune Defic Syndr 2004; 36: 890-899.
21. Toyoda H, Fukuda Y, Koyama Y, Nakano I, Kinoshita M, Hadama T, Takamatsu J, Hayakawa T: Nucleotide sequence diversity of hypervariable region 1 of hepatitis C virus in Japanese hemophiliacs with chronic hepatitis C and patients with chronic post-transfusion hepatitis C. Blood 1996; 88: 1488-1493.
22. Hartman C, Berkowitz D, Rimon N. Shamir R: The effect of early treatment in children with chronic hepatitis C. J Pediatr Gastroenterol Nutr 2003; 37: 252-257.